1,094
Views
6
CrossRef citations to date
0
Altmetric
Supplement 2, 2012

Probiotic viability – does it matter?

Article: 18567 | Published online: 18 Jun 2012

References

  • Joint FAO/WHO Working Group Report on Drafting for the Evaluation of Probiotics in Food. Guidelines for the evaluation of probiotics in food. LondonOntario, Canada: FAO/WHO. 2002.
  • Ouwehand AC, Tölkkö S, Kulmala J, Salminen S, Salminen E. Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol. 2000; 31: 82–6. 10.3402/mehd.v23i0.18567.
  • Hood SK, Zottola EA. Effect of low pH on the ability of Lactobacillus acidophilus to survive and adhere to human intestinal cells. J Food Sci. 1988; 53: 1514–6. 10.3402/mehd.v23i0.18567.
  • Tuomola EM, Ouwehand AC, Salminen SJ. Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins. Int J Food Microbiol. 2000; 60: 75–81. 10.3402/mehd.v23i0.18567.
  • Maldonado Galdeano C, Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol. 2004; 97: 673–81. 10.3402/mehd.v23i0.18567.
  • Chauviere G, Coconnier MH, Kerneis S, Darfeuille-Michaud A, Joly B, Servin AL. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus. FEMS Microbiol Lett. 1992; 70: 213–7. 10.3402/mehd.v23i0.18567.
  • Montalto M, Maggiano N, Ricci R, Curigliano V, Santoro L, Di Nicuolo F, et al. Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion. 2004; 69: 225–8. 10.3402/mehd.v23i0.18567.
  • Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem. 2002; 277: 50959–65. 10.3402/mehd.v23i0.18567.
  • Solis Pereyra B, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res. 1993; 13: 1127–40. 10.3402/mehd.v23i0.18567.
  • Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol. 2003; 10: 259–66.
  • Rachmilewitz D, Karmeli F, Takabayashi K, Hayashi T, Leider-Trejo L, Lee J, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 2002; 122: 1428–41. 10.3402/mehd.v23i0.18567.
  • Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, et al. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol. 2006; 145: 130–8. 10.3402/mehd.v23i0.18567.
  • Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A. 2008; 105: 19474–9. 10.3402/mehd.v23i0.18567.
  • Kotani Y, Shinkai S, Okamatsu H, Toba M, Ogawa K, Yoshida H, et al. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing. 2010; 7: 11. 10.3402/mehd.v23i0.18567.
  • Hirose Y, Murosaki S, Yamamoto Y, Yoshikai Y, Tsuru T. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J Nutr. 2006; 136: 3069–73.
  • van Baarlen P, Troost FJ, van Hemert S, van der MC, de Vos WM, de Groot PJ, et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A. 2009; 106: 2371–6. 10.3402/mehd.v23i0.18567.
  • Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun. 2000; 68: 752–9. 10.3402/mehd.v23i0.18567.
  • Korhonen R, Korpela R, Saxelin M, Maki M, Kankaanranta H, Moilanen E. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation. 2001; 25: 223–32. 10.3402/mehd.v23i0.18567.
  • Perdigón G, de Macias ME, Alvarez S, Oliver G, de Ruiz Holgado AA. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun. 1986; 53: 404–10.
  • Gill HS, Rutherfurd KJ. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr. 2001; 86: 285–9. 10.3402/mehd.v23i0.18567.
  • Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun. 1996; 64: 5403–5.
  • Lee Y, Lee TS. Enhancement in ex vivo phagocytic capacity of peritoneal leukocytes in mice by oral delivery of various lactic-acid-producing bacteria. Curr Microbiol. 2005; 50: 24–7. 10.3402/mehd.v23i0.18567.
  • Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun. 2004; 72: 5308–14. 10.3402/mehd.v23i0.18567.
  • De Simone C, Vesely R, Negri R, Bianchi Salvadori B, Zanzoglu S, Cilli A, et al. Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt. Immunopharmacol Immunotoxicol. 1987; 9: 87–100. 10.3402/mehd.v23i0.18567.
  • Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. Immune system stimulation by probiotics. J Dairy Sci. 1995; 78: 1597–606. 10.3402/mehd.v23i0.18567.
  • Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun. 2003; 71: 428–36. 10.3402/mehd.v23i0.18567.
  • Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A. 2005; 102: 2880–5. 10.3402/mehd.v23i0.18567.
  • Xiao SD, Zhang de Z, Lu H, Jiang SH, Liu HY, Wang GS, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003; 20: 253–60. 10.3402/mehd.v23i0.18567.
  • Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child. 1995; 72: 51–3. 10.3402/mehd.v23i0.18567.
  • Ouwehand AC, Salminen S. The health effects of cultured milk products with viable and non-viable bacteria. Int Dairy J. 1998; 8: 749–58. 10.3402/mehd.v23i0.18567.
  • Tsuchiya J, Barreto R, Okura R, Kawakita S, Fesce E, Marotta F. Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome. Chin J Dig Dis. 2004; 5: 169–74. 10.3402/mehd.v23i0.18567.
  • Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 2009; 14: 97–107.
  • Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther. 2000; 14: 1625–9. 10.3402/mehd.v23i0.18567.
  • de Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr. 2002; 88: S59–66. 10.3402/mehd.v23i0.18567.
  • Cats A, Kuipers EJ, Bosschaert MA, Pot RG, Vandenbroucke-Grauls CM, Kusters JG. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther. 2003; 17: 429–35. 10.3402/mehd.v23i0.18567.
  • Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition. 2003; 19: 716–21. 10.3402/mehd.v23i0.18567.
  • Lerebours E, N'Djitoyap Ndam C, Lavoine A, Hellot MF, Antoine JM, Colin R. Yogurt and fermented-then-pasteurized milk: effects of short-term and long-term ingestion on lactose absorption and mucosal lactase activity in lactase-deficient subjects. Am J Clin Nutr. 1989; 49: 823–7.
  • Pelletier X, Laure-Boussuge S, Donazzolo Y. Hydrogen excretion upon ingestion of dairy products in lactose-intolerant male subjects: importance of the live flora. Eur J Clin Nutr. 2001; 55: 509–12. 10.3402/mehd.v23i0.18567.
  • de Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J. Probiotics – compensation for lactase insufficiency. Am J Clin Nutr. 2001; 73: 421S–9S.
  • Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003; 36: 223–7. 10.3402/mehd.v23i0.18567.
  • Van de Water J, Keen CL, Gershwin ME. The influence of chronic yogurt consumption on immunity. J Nutr. 1999; 129: 1492S–5S.
  • Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol. 2005; 16: 433–8. 10.3402/mehd.v23i0.18567.
  • Ishida Y, Nakamura F, Kanzato H, Sawada D, Yamamoto N, Kagata H, et al. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem. 2005; 69: 1652–60. 10.3402/mehd.v23i0.18567.
  • Okawa T, Kita M, Arai T, Iida K, Dokiya T, Takegawa Y, et al. Phase II randomized clinical trial of LC9018 concurrently used with radiation in the treatment of carcinoma of the uterine cervix. Its effect on tumor reduction and histology. Cancer. 1989; 64: 1769–76.
  • Okawa T, Niibe H, Arai T, Sekiba K, Noda K, Takeuchi S, et al. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study. Cancer. 1993; 72: 1949–54.
  • Masuno T, Kishimoto S, Ogura T, Honma T, Niitani H, Fukuoka M, et al. A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer. Cancer. 1991; 68: 1495–500.
  • Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol. 1994; 16: 29–36. 10.3402/mehd.v23i0.18567.
  • El-Nezami H, Kankaanpää P, Salminen S, Ahokas J. Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J Food Prot. 1998; 61: 466–8.
  • Lahtinen SJ, Gueimonde M, Ouwehand AC, Reinikainen JP, Salminen SJ. Probiotic bacteria may become dormant during storage. Appl Environ Microbiol. 2005; 71: 1662–3. 10.3402/mehd.v23i0.18567.